RudaCure has been selected for the 2021 Physician 初创企业 Joint Research Infrastructure Building Support Project organized by the 韩国健康产业振兴院, and will receive support for one year.
Through this project, RudaCure will strengthen collaboration with Kangwon National University, 韩国 University, Catholic Medical Center 首尔 St. Mary's Hospital, 仁川 St. Mary's Hospital, 首尔 Asan Hospital, and Severance Hospital, and will establish a foundation for the successful execution of 临床试验 and 联合研究 for RCI001.
Through this, the company will develop clinical indicators, conduct mechanism studies on RCI001, actively address issues that may arise during 临床试验, and develop product technology commercialization strategies and clinical protocols.
In addition, these researchers will investigate additional indications based on RCI001 and aim to identify new research projects based on their findings.
https://www.bosa.co.kr/news/articleView.html?idxno=2146689